Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of docetaxel polymer nano injection and preparation method thereof

A docetaxel and polymer technology, applied in the field of medicine, can solve the problems of too fast release, easy sudden release to the whole body, poor water solubility, etc., and achieve the effects of enhancing water solubility, improving therapeutic effect, and improving stability

Active Publication Date: 2022-07-19
四川美大康佳乐药业有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] But the water solubility of docetaxel is poor, almost insoluble in water, prior art adopts Tween80 solubilization, ethanol solubilization to make pharmaceutical preparation; Because the existence of Tween80 makes this preparation in clinical use process can cause as allergic reaction, Severe adverse reactions such as neurotoxicity; and after docetaxel enters the body, the distribution is non-selective and reaches various tissues and organs throughout the body, thereby causing systemic toxic and side effects, and easily causing toxicity to the nervous system and immune system, especially neutropenia Such as immune system toxicity, which greatly harms the physical and mental health of patients, which limits its clinical application; in addition, the stability of docetaxel is limited, and it must be used within 4 hours after clinical preparation, which limits the administration of docetaxel
[0004] At present, the existing technology solves the problem of poor water solubility of docetaxel by coating water-soluble polymer micelles on the surface of docetaxel, but its coating stability is still limited, and it will also be released suddenly when placed It is not highly resistant, it is inconvenient to apply, and it is easy to release suddenly after entering the body, which will bring systemic toxic and side effects; in addition, it is released too quickly after entering the body, and the therapeutic effect on tumor cells is not good.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of docetaxel polymer nano injection and preparation method thereof
  • A kind of docetaxel polymer nano injection and preparation method thereof
  • A kind of docetaxel polymer nano injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] This embodiment provides a docetaxel polymer nano-injection, including the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel is composed of a shell The cross-linked polymer is coated and modified; the modified docetaxel and the chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the chlorin.

[0038] The present embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0039] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0040] S2: Dissolve docetaxel and PPhe-PLys-PEG shell cross-linked polymer in methanol solution at a mass ratio of 1:2.5, heat at 30°C for 11 hours, and then evaporate the solvent to obtain modified docetaxel;

[0041] S3: Dissolve modified docetaxel and chlorphene in THF at a mass ratio of 1:1 under argon, add 10 drops of toluenesulfonic acid dropwise, stir and react at 35°C for 4 hours, and then pres...

Embodiment 2

[0044]This embodiment provides a docetaxel polymer nano-injection, including the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel is composed of a shell The cross-linked polymer is coated and modified; the modified docetaxel and the chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the chlorin.

[0045] The present embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0046] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0047] S2: Dissolve docetaxel and PPhe-PLys-PEG shell cross-linked polymer in methanol solution at a mass ratio of 1:3, heat at 35°C for 10 hours and then evaporate the solvent to obtain modified docetaxel;

[0048] S3: Dissolve modified docetaxel and chlorphene in THF at a mass ratio of 1:2 under argon, add 20 drops of toluenesulfonic acid dropwise, stir and react at 45°C for 3 hours, and then press th...

Embodiment 3

[0051] This embodiment provides a docetaxel polymer nano-injection, including the following components: modified docetaxel, chlorin and PCL-acylamide-PEG; the modified docetaxel is composed of a shell The cross-linked polymer is coated and modified; the modified docetaxel and the chlorin are connected through an orthoester bond; the PCL-acylamide-PEG is coated on the chlorin.

[0052] The present embodiment also provides a preparation method of docetaxel polymer nano-injection, comprising the following steps:

[0053] S1: pre-prepared PPhe-PLys-PEG shell cross-linked polymer;

[0054] S2: Dissolve docetaxel and PPhe-PLys-PEG shell cross-linked polymer in methanol solution at a mass ratio of 1:2, heat at 25°C for 12 hours and then evaporate the solvent to obtain modified docetaxel;

[0055] S3: Dissolve modified docetaxel and chlorphene in THF at a mass ratio of 1:1.5 under argon, add 15 drops of toluenesulfonic acid dropwise, stir and react at 40°C for 3 hours, and then press...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a docetaxel polymer nano-injection, comprising the following components: modified docetaxel, a photosensitizer and a pH-sensitive block; the modified docetaxel is cross-linked by a shell polymer Coating modification; the modified docetaxel and the photosensitizer are connected through an acid-sensitive bond; the pH-sensitive block is coated outside the photosensitizer. The invention also provides a preparation method of the docetaxel polymer nano injection. The present invention enables docetaxel to have higher water solubility and higher stability, is not easy to cause systemic toxic and side effects due to sudden release, and can be released slowly. At the same time, the combined treatment of chemotherapy and phototherapy can effectively improve the effect on tumor cells. treatment effect.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a docetaxel polymer nano-injection and a preparation method thereof. Background technique [0002] Taxanes play an important role in the treatment of various solid tumors; docetaxel, a second-generation semi-synthetic taxane derivative, is approximately twice as potent as paclitaxel in participating in microtubule depolymerization, inhibiting Cell division is used to treat advanced breast cancer, non-small cell lung cancer and other tumor diseases. [0003] However, the water solubility of docetaxel is poor, and it is almost insoluble in water, and the prior art adopts Tween80 solubilization and ethanol solubilization to prepare a pharmaceutical preparation; due to the existence of Tween80, the preparation can cause allergic reactions, such as allergic reactions, Serious adverse reactions such as neurotoxicity; and after docetaxel enters the body, it is not selectively distribu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/08A61K31/337A61K41/00A61K9/50A61K47/34A61K47/55A61P35/00
CPCA61K31/337A61K47/55A61K41/0071A61K9/0019A61K9/08A61P35/00A61K9/5073A61K9/5031A61K2300/00
Inventor 张祝君秦方云刘晓娟杨丹洲
Owner 四川美大康佳乐药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products